| Risk | High |
|---|---|
| Min SIP Amount | ₹500 |
| Expense Ratio | 2.25% |
| NAV | ₹28.36 (30 Sep 2020) |
|---|---|
| Fund Started | 26 Dec 2007 |
| Fund Size | ₹917 Cr |
| Name | Sector | Instrument | % Assets |
|---|---|---|---|
| PI Industries Ltd. | Chemicals | Equity | 4.6% |
| Ipca Laboratories Ltd. | Healthcare | Equity | 4.2% |
| Dixon Technologies (India) Ltd. | Engineering | Equity | 3.6% |
| Tata Consumer Products Ltd. | FMCG | Equity | 3.4% |
| Jubilant FoodWorks Ltd. | Services | Equity | 3.4% |
| Coromandel International Ltd. | Chemicals | Equity | 3.2% |
| Cholamandalam Investment & Finance Co. Ltd. | Financial | Equity | 3.1% |
| SRF Ltd. | Diversified | Equity | 3.0% |
| Federal Bank Ltd. | Financial | Equity | 3.0% |
| Max Financial Services Ltd. | Financial | Equity | 2.8% |
Edelweiss Mid Cap Fund Regular Growth is a Equity Mutual Fund Scheme launched by Edelweiss Mutual Fund. This scheme was made available to investors on 26 Dec 2007. Harshad Patwardhan is the Current Fund Manager of Edelweiss Mid Cap Fund Regular Growth fund.The fund currently has an Asset Under Management(AUM) of ₹917 Cr and the Latest NAV as of 30 Sep 2020 is ₹28.36.
The Edelweiss Mid Cap Fund Regular Growth is rated High risk. Minimum SIP Investment is set to 500. Minimum Lumpsum Investment is 5000. Exit load of 1% if redeemed within 12 months